Exploratory Study of the Effect of Omega-3-acid Ethyl Esters on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Takeda Pharma
- 04 Jul 2017 Planned primary completion date changed from 1 Aug 2017 to 31 Aug 2017.
- 04 Jul 2017 Planned number of patients changed from 40 to 37.
- 04 Jul 2017 Status changed from recruiting to active, no longer recruiting.